These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
255 related items for PubMed ID: 30000712
21. The Guinea pig as a preclinical model for demonstrating the efficacy and safety of statins. Madsen CS, Janovitz E, Zhang R, Nguyen-Tran V, Ryan CS, Yin X, Monshizadegan H, Chang M, D'Arienzo C, Scheer S, Setters R, Search D, Chen X, Zhuang S, Kunselman L, Peters A, Harrity T, Apedo A, Huang C, Cuff CA, Kowala MC, Blanar MA, Sun CQ, Robl JA, Stein PD. J Pharmacol Exp Ther; 2008 Feb; 324(2):576-86. PubMed ID: 17986646 [Abstract] [Full Text] [Related]
29. Lipid-lowering and antiatherosclerotic effect of NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in Watanabe heritable hyperlipidemic rabbits. Suzuki H, Yamazaki H, Aoki T, Kojima J, Tamaki T, Sato F, Kitahara M, Saito Y. Arzneimittelforschung; 2000 Nov 23; 50(11):995-1003. PubMed ID: 11187394 [Abstract] [Full Text] [Related]
30. (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1h-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid (BMS-644950): a rationally designed orally efficacious 3-hydroxy-3-methylglutaryl coenzyme-a reductase inhibitor with reduced myotoxicity potential. Ahmad S, Madsen CS, Stein PD, Janovitz E, Huang C, Ngu K, Bisaha S, Kennedy LJ, Chen BC, Zhao R, Sitkoff D, Monshizadegan H, Yin X, Ryan CS, Zhang R, Giancarli M, Bird E, Chang M, Chen X, Setters R, Search D, Zhuang S, Nguyen-Tran V, Cuff CA, Harrity T, Darienzo CJ, Li T, Reeves RA, Blanar MA, Barrish JC, Zahler R, Robl JA. J Med Chem; 2008 May 08; 51(9):2722-33. PubMed ID: 18412317 [Abstract] [Full Text] [Related]
31. Pitavastatin: a new HMG-CoA reductase inhibitor. Wensel TM, Waldrop BA, Wensel B. Ann Pharmacother; 2010 Mar 08; 44(3):507-14. PubMed ID: 20179258 [Abstract] [Full Text] [Related]
34. Cholesterol-lowering effect of NK-104, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, in guinea pig model of hyperlipidemia. Aoki T, Yamazaki H, Suzuki H, Tamaki T, Sato F, Kitahara M, Saito Y. Arzneimittelforschung; 2001 Mar 08; 51(3):197-203. PubMed ID: 11304935 [Abstract] [Full Text] [Related]
35. Pitavastatin: efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor. Kajinami K, Takekoshi N, Saito Y. Cardiovasc Drug Rev; 2003 Mar 08; 21(3):199-215. PubMed ID: 12931254 [Abstract] [Full Text] [Related]